Foresight Raises $5.5M Seed Round to Bring Unified Data and AI to the Private Market
26.6.2025 14:07:00 EEST | Business Wire | Press release
Foresight, the New York City based software company on a mission to connect the private market through data, today announced the close of a $5.5 million seed funding round led by NEA with participation from KDX Ventures. In conjunction with the financing, Madison Faulkner, a partner on NEA’s Technology Investing Team, will join Foresight’s board of directors.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250626393402/en/
Foresight's founders, Adam Devine (CRO) and Jason Miller (CEO)
Founded in 2023, Foresight helps private market investors, lenders, and acquirers use data to make financial decisions about private companies. Through its proprietary AI-driven data mesh, the Foresight platform unifies data from 50+ sources and applications, including third-party sourcing feeds, CRMs, cap table vendors, shared drives, company KPIs, and fund accounting software. This single source of truth is integrated into the dashboards, analytics, and modeling tools within Foresight’s SaaS applications for sourcing, diligence, and post-investment portfolio management.
“Private markets are fragmented—filled with point solutions and siloed data. Everyone is chasing the elusive 'single pane of glass' to make sense of it all,” said Jason Miller, Founder & CEO, Foresight. “But unifying and structuring that data into a seamless, usable knowledge graph was a fundamental, unsolved problem until Foresight.” Miller, a West Point grad and Army veteran, has spent his entire business career building technology for the private markets, including a decade at BlackRock and several years at Point72 and Greycroft, where he identified the ubiquitous problem of siloed data.
“The private market is at the inflection point that every industry goes through during the adoption of new technology and the shift to becoming data-driven,” said Adam Devine, Foresight Co-founder and CRO. “Foresight helps every type of private company investor, banker, and acquirer to become powered by data and will enable new ways for market participants to engage, collaborate and transact with one another.” Devine is a serial entrepreneur and has led go-to-market for several AI-driven enterprise software companies.
Since launching with founding customers in April 2023, Foresight’s software has been deployed within some the most sophisticated venture capital and private equity firms, such as Forerunner and Kleiner Perkins, and the company has created partnerships with several of the private market’s biggest data and services companies.
“We believe Foresight enables every type of private company investor, banker, and acquirer to become data-driven,” said Madison Faulkner, Partner, NEA. “I have known Jason for years as an industry expert with a deep understanding of how to effectively use data in the private markets. When NEA first saw Foresight’s product, we quickly understood the firm-wide value it could deliver—from investing to services and operations. We’re thrilled to partner with Jason, Adam, and the team as they work to deliver precision around structured data for private market-focused businesses.”
Foresight plans to use the infusion of capital to expand its product and GTM teams and encourages applications through its careers page. The team is headquartered in New York City with a presence in San Francisco.
About Foresight
The smartest private market professionals use Foresight’s platform to make their best sourcing, diligence, and portfolio management decisions. Foresight’s AI-driven infrastructure unifies every source of pre- and post-investment private company data (sourcing feeds, CRM, KPI, cap table, fund accounting) and builds this single source of truth into SaaS modules for filtering the universe of companies, managing deal pipelines, and collecting, monitoring, and modeling company and fund performance. By solving the industry-wide problem of siloed data and disconnected point tools, Foresight makes each member of every team at a private fund smarter, faster, and more efficient. Foresight’s customers range from newer venture managers that want to super-charge growth to global private equity firms committed to data-driven transformation. Foresight is headquartered in New York City with an office in San Francisco and is backed by NEA, Greycroft, and KDX Ventures. For more information, please visit www.foresightdata.com.
About NEA
New Enterprise Associates, Inc. (NEA) is a global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies. Founded in 1977, NEA has more than $27 billion in assets under management as of December 31, 2024, and invests in technology and healthcare companies at all stages in a company’s lifecycle, from seed stage through IPO. The firm’s long track record of investing includes more than 280 portfolio company IPOs and more than 470 mergers and acquisitions. For more information, please visit www.nea.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250626393402/en/
Contacts
Media Contact
Adam Devine: adam@foresightdata.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 23:01:00 EEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 14:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 13:50:00 EEST | Press release
IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio transformation and is expected to strengthen the company’s focus on its innovation-driven businesses: Taste, Scent, and Health & Biosciences. Following the transaction, IFF will be
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom